Skip to main content

Table 1 Antibodies used in this study

From: FABP7 is a potential biomarker to predict response to neoadjuvant chemotherapy for breast cancer

Antibody

Cat.#

Company

Concentration species

FABP7

D8N3N

Gene biotechnology international trade (Shanghai)

1:1000, rabbit

ESRα

D6R2W

CST

1:2000, rabbit

Anti-Cdh1

DH01

Calbiochem(La Jolla, CA, USA)

1:2000, mouse

Abti-p27kip1

SC-56338

Santa Cruz Biotechnology Inc. (Santa Cruz, CA, USA)

1:2000, mouse

Anti-Skp2

SC-7164

Santa Cruz Biotechnology Inc.

1:2000, rabbit

Anti βactin

8H10D10

CST

1:2000, mouse